Unveiling Antimicrobial and Anticancer Functionalities

Chih-Ching Yen,Pei-Ying Wu,Huan Ou-Yang,Hsiao-Ling Chen,Kowit-Yu Chong,Ro-Lin Chang,Chuan-Mu Chen

DOI: https://doi.org/10.3390/ijms25031818

IF: 5.6

2024-02-03

International Journal of Molecular Sciences

Abstract:Lactoferrin (LF) stands as one of the extensively investigated iron-binding glycoproteins within milk, exhibiting diverse biological functionalities. The global demand for LF has experienced consistent growth. Biotechnological strategies aimed at enhancing LF productivity through microbial expression systems offer substantial cost-effective advantages and exhibit fewer constraints compared to traditional animal bioreactor technologies. This study devised a novel recombinant plasmid, wherein the AOX1 promoter was replaced with a glucose-inducible G1 promoter (PG1) to govern the expression of recombinant porcine LF (rpLF) in Pichia pastoris GS115. High-copy-number PG1-rpLF yeast clones were meticulously selected, and subsequent induction with 0.05 g/L glucose demonstrated robust secretion of rpLF. Scaling up production transpired in a 5 L fermenter, yielding an estimated rpLF productivity of approximately 2.8 g/L by the conclusion of glycerol-fed fermentation. A three-step purification process involving tangential-flow ultrafiltration yielded approximately 6.55 g of rpLF crude (approximately 85% purity). Notably, exceptional purity of rpLF was achieved through sequential heparin and size-exclusion column purification. Comparatively, the present glucose-inducible system outperformed our previous methanol-induced system, which yielded a level of 87 mg/L of extracellular rpLF secretion. Furthermore, yeast-produced rpLF demonstrated affinity for ferric ions (Fe3+) and exhibited growth inhibition against various pathogenic microbes (E. coli, S. aureus, and C. albicans) and human cancer cells (A549, MDA-MB-231, and Hep3B), similar to commercial bovine LF (bLF). Intriguingly, the hydrolysate of rpLF (rpLFH) manifested heightened antimicrobial and anticancer effects compared to its intact form. In conclusion, this study presents an efficient glucose-inducible yeast expression system for large-scale production and purification of active rpLF protein with the potential for veterinary or medical applications.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

This paper aims to address the efficient production of biologically active porcine lactoferrin (pLF) in Pichia pastoris using a novel glucose-induced expression system and to reveal its antibacterial and anticancer functions.

Specifically:
1. **Development of a novel expression system**: The research team designed a new recombinant plasmid, replacing the original AOX1 promoter with a glucose-induced G1 promoter, to express recombinant porcine lactoferrin (rpLF) in Pichia pastoris GS115.
2. **Increasing yield**: High-efficiency secretion of rpLF was achieved through the selection of high-copy yeast clones and glucose induction. During scale-up production in a 5-liter fermenter, an rpLF yield of approximately 2.8 g/L was obtained.
3. **Purification techniques**: High-purity rpLF protein (approximately 85% purity) was obtained through multi-step purification processes such as tangential flow ultrafiltration.
4. **Functional validation**: The iron-binding, antibacterial, and anticancer functions of rpLF and its hydrolysates (rpLFH) were studied and compared with commercial bovine lactoferrin (bLF).

In summary, this study aims to develop an efficient glucose-induced expression system to achieve large-scale production of biologically active rpLF and to evaluate its potential application value.